Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Baltimore, Maryland 21201


Purpose:

To evaluate the long-term safety of pregabalin in refractory partial epilepsy.


Criteria:

Inclusion Criteria: - Must have met the inclusion criteria for preceding double-blind study. - Have received double-blind study medication and wish to receive open-label pregabalin. Exclusion Criteria: - Pregnant or considering becoming pregnant. - Receiving any concomitant medication that could alter the effectiveness of their medication response or seizure frequency.


NCT ID:

NCT00141414


Primary Contact:

Study Director
Pfizer CT.gov Call Center
Pfizer


Backup Contact:

N/A


Location Contact:

Baltimore, Maryland 21201
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.